KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Gross Margin (2016 - 2024)

Novartis Ag's Gross Margin history spans 13 years, with the latest figure at 77.52% for Q2 2024.

  • On a quarterly basis, Gross Margin rose 650.0% to 77.52% in Q2 2024 year-over-year; TTM through Jun 2024 was 14280.11%, a 1420910.0% increase, with the full-year FY2025 number at 78.81%, up 151.0% from a year prior.
  • Gross Margin hit 77.52% in Q2 2024 for Novartis Ag, up from 74.02% in the prior quarter.
  • Over the last five years, Gross Margin for NVS hit a ceiling of 7563025.21% in Q3 2020 and a floor of 0.14% in Q2 2022.
  • Historically, Gross Margin has averaged 596098.33% across 5 years, with a median of 71.85% in 2023.
  • Biggest five-year swings in Gross Margin: plummeted -756301592bps in 2021 and later skyrocketed 154319665bps in 2023.
  • Tracing NVS's Gross Margin over 5 years: stood at 11.16% in 2020, then crashed by -100bps to 0.03% in 2021, then soared by 21621085bps to 7201.57% in 2022, then tumbled by -99bps to 74.02% in 2023, then increased by 5bps to 77.52% in 2024.
  • Business Quant data shows Gross Margin for NVS at 77.52% in Q2 2024, 74.02% in Q4 2023, and 71.01% in Q2 2023.